APAS Independence with Urine Analysis Module

The APAS Independence with Urine Analysis Module is an automated in vitro diagnostic system designed to streamline the screening of urine cultures for microbial growth. It utilizes automated plate handling, high-resolution imaging, and sophisticated software algorithms to analyze microbial colonies on agar plates, providing semi-quantitative results to aid in the diagnosis of urinary tract infections and improve laboratory efficiency.

The APAS Independence with Urine Analysis Module is an in vitro diagnostic system designed for microbiology laboratories to automate the initial screening of urine culture plates. Its purpose is to detect the presence or absence of microbial growth and provide a semi-quantitative assessment of colony counts, aiding in the diagnosis of urinary tract infections (UTIs). The system employs an automated plate handling mechanism to move culture plates (inoculated with 1μL urine samples on Blood and MacConkey Agars and incubated for 18-22 hours) through an imaging station. Captured images are then analyzed by specialized software, which uses image assessment algorithms to determine growth status, enabling microbiologists to efficiently screen out negative samples and focus on those with potential growth. Performance data demonstrated the system's safety and effective software operation. The system's clinical capabilities are founded on the same core imaging and analysis technology used in the earlier APAS Compact model. A direct method comparison study involving 350 clinical urine samples further validated the APAS Independence, showing high agreement with the APAS Compact in plate designation (Positive, Review, Negative) and colony counts on both blood and MacConkey agar. The APAS Independence tended to be slightly more conservative, assigning "Positive" or "Review" more frequently or overestimating colony counts, ensuring that all plates with identified growth are reviewed by a microbiologist. Colony morphology detection also showed high concordance (>95%), and reproducibility and precision studies confirmed consistent performance comparable to the APAS Compact.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the image analysis algorithm differentiate between various colony morphologies and artifacts on the culture media, especially in mixed cultures?; What is the system's reported sensitivity and specificity for detecting common uropathogens at clinically significant thresholds (e.g., ≥10^5 CFU/mL) compared to manual reading by experienced microbiologists, beyond comparison with the APAS Compact?; How does the automated plate handling system manage variations in plate types (e.g., different manufacturers, bi-plates) and potential mechanical issues like plate jams or misfeeds?; What is the typical throughput of the APAS Independence system (plates per hour), and how does this integrate into the workflow of a high-volume clinical microbiology laboratory?; Are there any studies on the impact of pre-analytical variables (e.g., urine collection method, transport time, specimen quality) on the performance of the APAS Independence image analysis?